Cryo Cell International (CCEL) Other Operating Expenses (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Other Operating Expenses data on file, last reported at $1.8 million in Q1 2026.

• Quarterly Other Operating Expenses fell 15.44% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $12.2 million (up 39.31% YoY) and the FY2025 annual result came in at $11.6 million, up 34.1% from the prior year.
• Other Operating Expenses declined to $1.8 million in Q1 2026 per CCEL's latest filing, from $6.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $18.2 million in Q4 2023 and bottomed at $1.8 million in Q4 2024.
• The 5-year median for Other Operating Expenses is $2.3 million (2024), against an average of $3.4 million.
• The widest annual swing landed in 2023, when Other Operating Expenses soared 600.25%; it then plunged 89.91% in 2024.
• Tracing CCEL's Other Operating Expenses over 5 years: stood at $2.6 million in 2022, then soared by 600.25% to $18.2 million in 2023, then sank by 89.91% to $1.8 million in 2024, then jumped by 242.49% to $6.3 million in 2025, then tumbled by 70.68% to $1.8 million in 2026.
• Per Business Quant, the three latest CCEL Other Operating Expenses figures stand at $1.8 million (Q1 2026), $6.3 million (Q4 2025), and $2.0 million (Q3 2025).

Peer Comparison